Patents by Inventor Declan Forde

Declan Forde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240076599
    Abstract: An electroporation apparatus has an electroporation probe terminals for linking with electrodes. A foam is injected at the treatment site to displace blood rather than mixing with it, increasing the contact time of a higher concentration of active agent with the tissue and thus resulting in greater efficacy. With foam solutions, a lower concentration of agent can be used to obtain the same therapeutic effect as in their liquid counterpart, reducing the prevalence of side effects associated with higher concentrations. A foam solution compared to an equivalent liquid solution enables more efficient cell electroporation particularly where bipolar pulses have been employed by mitigating an increase in tissue conductivity as would normally be observed with a comparable liquid solution. A more efficient cell permeabilisation would result in better results where electroporation is being delivered alone or as a tool to aid in the uptake of molecules into the cell.
    Type: Application
    Filed: October 18, 2023
    Publication date: March 7, 2024
    Applicant: MIRAI MEDICAL LIMITED
    Inventors: Declan SODEN, Colin FORDE, Sean KINSELLA, Tony MOORE
  • Patent number: 11912975
    Abstract: An electroporation apparatus has an electroporation probe terminals for linking with electrodes. A foam is injected at the treatment site to displace blood rather than mixing with it, increasing the contact time of a higher concentration of active agent with the tissue and thus resulting in greater efficacy. With foam solutions, a lower concentration of agent can be used to obtain the same therapeutic effect as in their liquid counterpart, reducing the prevalence of side effects associated with higher concentrations. A foam solution compared to an equivalent liquid solution enables more efficient cell electroporation particularly where bipolar pulses have been employed by mitigating an increase in tissue conductivity as would normally be observed with a comparable liquid solution. A more efficient cell permeabilization would result in better results where electroporation is being delivered alone or as a tool to aid in the uptake of molecules into the cell.
    Type: Grant
    Filed: September 1, 2020
    Date of Patent: February 27, 2024
    Assignee: MIRAI MEDICAL LIMITED
    Inventors: Declan Soden, Colin Forde, Sean Kinsella, Tony Moore
  • Publication number: 20170007260
    Abstract: Described herein are various devices, assemblies and kits for creating vascular occlusions and various methods for creating vascular occlusions using such devices, assemblies and kits.
    Type: Application
    Filed: July 9, 2016
    Publication date: January 12, 2017
    Inventors: John-Allen O'Brien, Frank Ryan, Conor O'Sullivan, Eric Kruschke, Declan Forde